What is Intuitive Surgical's market cap?

Intuitive Surgical (ISRG) has a market capitalization of $147.01B and trades on NASDAQ.

What is Intuitive Surgical's revenue and profitability?

Intuitive Surgical generated $10.6B in trailing twelve-month revenue with net income of $3.0B, representing a net margin of 28.2%. Gross margin stands at 66.3%, with free cash flow of $2.8B. These figures are based on the Q1 2026 filing.

Who are Intuitive Surgical's competitors?

Intuitive Surgical's key competitors include Stryker Corporation, Medtronic plc, Johnson & Johnson, and others. These companies compete in similar markets and product categories.

Who does Intuitive Surgical partner with?

Intuitive Surgical's notable partners include Baxter International Inc., Fosun Pharma.

What subsidiaries does Intuitive Surgical have?

Intuitive Surgical's subsidiaries include Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd..

Where is Intuitive Surgical headquartered?

Intuitive Surgical is headquartered in United States of America and employs approximately 13,676 people. It has been publicly traded since 2000.

Intuitive Surgical

ISRG

Intuitive Surgical is a global leader in robotic-assisted, minimally invasive care technology.

Market cap

$147.01B-24.7%

Revenue$10.6B+21.4%

Net income$3.0B+20.3%

Free cash flow$2.8B+62.4%

EPS (diluted)$8.24+20.6%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 21, 2026

Revenue$2.8BBeat by $152.1M EPS$2.50Beat by $0.38

Read the full report

Next report

Jul 16, 2026 (In 6 days)

Revenue estimate$2.8B

EPS estimate$2.48

Financials

Q1 2026

Income statement

See full

Revenue$2.8B+23.0%

Gross profit$1.8B+25.6%

Operating income$855.3M+48.0%

Net income$821.5M+17.6%

EPS (diluted)$2.28+18.7%

Balance sheet

See full

Cash & equivalents$2.1B-21.6%

Total equity$17.5B+2.2%

Total assets$20.1B+4.6%

Cash flow

See full

Operating cash flow$911.9M+56.8%

CapEx$103.3M-11.4%

Free cash flow$808.6M+73.9%

Valuation & ratios

Valuation

See full

Market cap$151.33B-24.7%

P/E50.8×-26.2×

P/S14.3×-7.7×

Profitability

See full

Gross margin66.3%-0.8pp

Operating margin30.5%+2.3pp

Net margin28.2%-0.3pp

FCF margin26.8%+6.8pp

Returns & leverage

See full

Return on equity17.2%+1.3pp

Current ratio4.6×-0.4×

Segments

By product

See full

Instruments and accessories$1.7B+23.3%

Systems$650.7M+24.5%

Service$433.7M+19.5%

Competitors

By market cap

Johnson & Johnson$643.30B+71.9%

Intuitive Surgical$151.33B-21.9%

Stryker$126.41B-15.6%

Medtronic$107.31B-5.1%

Merit Medical Systems$4.3B-22.1%

PROCEPT BioRobotics Corporation$1.2B—

Stereotaxis$177.9M-4.2%

Microbot Medical$127.6M+34.8%

By revenue growth

Microbot Medical+62.4%

PROCEPT BioRobotics Corporation+29.3%

Intuitive Surgical+21.4%

Stereotaxis+13.4%

Merit Medical Systems+11.1%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+7.9%

By net margin

Intuitive Surgical28.15%-0.3pp

Johnson & Johnson21.83%-2.6pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Merit Medical Systems9.03%+0.2pp

PROCEPT BioRobotics Corporation-31.82%+4.4pp

Stereotaxis-69.5%+22.7pp

Microbot Medical-3,669.88%+2,493pp

Profile

Intuitive Surgical is a global leader in robotic-assisted, minimally invasive care technology. The company develops, manufactures, and markets advanced robotic systems, instruments, and digital tools that enable physicians to perform complex procedures with greater precision and less invasiveness. Its core value proposition is centered on the 'Quintuple Aim': improving patient outcomes, enhancing the patient and care team experience, lowering the total cost of care, and expanding access to high-quality treatment.

Competitive position

The company is the dominant pioneer in the robotic-assisted surgery market with a massive installed base and a comprehensive ecosystem of instruments and digital services.

GeographiesUnited States, Europe, China, Japan, South Korea, India, Canada

Customer segmentsHospitals, Surgical specialists, Diagnostic clinics

Business modelRazor-and-blade, Capital equipment sales, Subscription services, Maintenance contracts

SuppliersCustom component manufacturers, Sole-source electronic component suppliers, Radiologists (for 3D modeling services), Software and algorithm developers

CustomersGeneral surgeons, Urologists, Gynecologists, Thoracic surgeons, Pulmonologists, Hospital procurement departments

CountryUnited States of America

Listed2000

Employees13.7K

CEODavid J. Rosa

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteintuitive.com

FilingsSEC EDGAR

Ask your AI about Intuitive Surgical.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intuitive Surgical's market cap?: Intuitive Surgical (ISRG) has a market capitalization of $147.01B and trades on NASDAQ.
What is Intuitive Surgical's revenue and profitability?: Intuitive Surgical generated $10.6B in trailing twelve-month revenue with net income of $3.0B, representing a net margin of 28.2%. Gross margin stands at 66.3%, with free cash flow of $2.8B. These figures are based on the Q1 2026 filing.
Who are Intuitive Surgical's competitors?: Intuitive Surgical's key competitors include Stryker Corporation, Medtronic plc, Johnson & Johnson, and others. These companies compete in similar markets and product categories.
Who does Intuitive Surgical partner with?: Intuitive Surgical's notable partners include Baxter International Inc., Fosun Pharma.
What subsidiaries does Intuitive Surgical have?: Intuitive Surgical's subsidiaries include Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd..
Where is Intuitive Surgical headquartered?: Intuitive Surgical is headquartered in United States of America and employs approximately 13,676 people. It has been publicly traded since 2000.